Emerging agents and regimens for hepatocellular carcinoma

por Zhu, Xiao-Dong, Sun, Hui-Chuan
Publicado 2019

Downstaging Conversion Therapy in Patients With Initially Unresectable Advanced Hepatocellular Carcinoma: An Overview

por Sun, Hui-Chuan, Zhu, Xiao-Dong
Publicado 2021

Targeting angiogenesis for liver cancer: Past, present, and future

por Zhu, Xiao-Dong, Tang, Zhao-You, Sun, Hui-Chuan
Publicado 2020

Adjuvant therapies after curative treatments for hepatocellular carcinoma: Current status and prospects

por Zhu, Xiao-Dong, Li, Kang-Shuai, Sun, Hui-Chuan
Publicado 2020

Immunotherapy in hepatocellular carcinoma: evaluation and management of adverse events associated with atezolizumab plus bevacizumab

por Hsu, Chiun, Rimassa, Lorenza, Sun, Hui-Chuan, Vogel, Arndt, Kaseb, Ahmed O.
Publicado 2021

Prognostic Roles of Cross-Talk between Peritumoral Hepatocytes and Stromal Cells in Hepatocellular Carcinoma Involving Peritumoral VEGF-C, VEGFR-1 and VEGFR-3

por Zhuang, Peng-Yuan, Shen, Jun, Zhu, Xiao-Dong, Lu, Lu, Wang, Lu, Tang, Zhao-You, Sun, Hui-Chuan
Publicado 2013

Impaired Spatial Learning and Memory after Sevoflurane–Nitrous Oxide Anesthesia in Aged Rats Is Associated with Down-Regulated cAMP/CREB Signaling

por Xiong, Wan-Xia, Zhou, Guo-Xia, Wang, Bei, Xue, Zhang-Gang, Wang, Lu, Sun, Hui-Chuan, Ge, Sheng-Jin
Publicado 2013

Cholelithiasis and the risk of intrahepatic cholangiocarcinoma: a meta-analysis of observational studies

por Cai, Hao, Kong, Wen-Tao, Chen, Chao-Bo, Shi, Guo-Ming, Huang, Cheng, Shen, Ying-Hao, Sun, Hui-Chuan
Publicado 2015

Blocking siglec-10(hi) tumor-associated macrophages improves anti-tumor immunity and enhances immunotherapy for hepatocellular carcinoma

por Xiao, Nan, Zhu, Xiaodong, Li, Kangshuai, Chen, Yifan, Liu, Xuefeng, Xu, Bin, Lei, Ming, Xu, Jiejie, Sun, Hui-Chuan
Publicado 2021

Direct Transformation of Lung Microenvironment by Interferon-α Treatment Counteracts Growth of Lung Metastasis of Hepatocellular Carcinoma

por Zhuang, Peng-Yuan, Shen, Jun, Zhu, Xiao-Dong, Zhang, Ju-Bo, Tang, Zhao-You, Qin, Lun-Xiu, Sun, Hui-Chuan
Publicado 2013

Peritumoral Cbl is a strong independent prognostic marker after curative resection of hepatocellular carcinoma

por Zhang, Ju-Bo, Zhang, Bo, Guo, Lei, Lin, Zhen-Hai, Li, Xiao-Qiang, Guo, Kun, Sun, Hui-Chuan, Ye, Qing-Hai
Publicado 2015

Intrahepatic cholangiocarcinoma patients without indications of lymph node metastasis not benefit from lymph node dissection

por Hu, Jie, Chen, Fei-Yu, Zhou, Kai-Qian, Zhou, Cheng, Cao, Ya, Sun, Hui-Chuan, Fan, Jia, Zhou, Jian, Wang, Zheng
Publicado 2017

PCSK9 promotes tumor growth by inhibiting tumor cell apoptosis in hepatocellular carcinoma

por Zhang, Shi-Zhe, Zhu, Xiao-Dong, Feng, Long-Hai, Li, Xiao-Long, Liu, Xue-Feng, Sun, Hui-Chuan, Tang, Zhao-You
Publicado 2021

Microvascular invasion has limited clinical values in hepatocellular carcinoma patients at Barcelona Clinic Liver Cancer (BCLC) stages 0 or B

por Huang, Cheng, Zhu, Xiao-Dong, Ji, Yuan, Ding, Guang-Yu, Shi, Guo-Ming, Shen, Ying-Hao, Zhou, Jian, Fan, Jia, Sun, Hui-Chuan
Publicado 2017

Serum PON1 as a biomarker for the estimation of microvascular invasion in hepatocellular carcinoma

por Ding, Guang-Yu, Zhu, Xiao-Dong, Ji, Yuan, Shi, Guo-Ming, Shen, Ying-Hao, Zhou, Jian, Fan, Jia, Sun, Hui-Chuan, Huang, Cheng
Publicado 2020

Peripheral naïve CD8(+) T cells as a predictive biomarker of response to lenvatinib plus an anti‐PD‐1 antibody in advanced hepatocellular carcinoma: a biomarker study

por Huang, Cheng, Xu, Bin, Zhu, Xiao‐Dong, Shen, Ying‐Hao, Li, Mei‐Ling, Zhu, Jin‐Jin, Zhou, Jian, Fan, Jia, Sun, Hui‐Chuan
Publicado 2022

Effectiveness and safety of lenvatinib plus anti‐programmed death‐1 antibodies in patients with hepatocellular carcinoma: A real‐world cohort study

por Xu, Ming‐Hao, Huang, Cheng, Li, Mei‐Ling, Zhu, Xiao‐Dong, Tan, Chang‐Jun, Zhou, Jian, Fan, Jia, Sun, Hui‐Chuan, Shen, Ying‐Hao
Publicado 2023

The Safety Profile of Hepatectomy Following Preoperative Systemic Therapy with Lenvatinib Plus Anti-PD-1 Antibodies Versus Hepatectomy Alone in Patients With Hepatocellular Carcino...

por Shen, Ying-Hao, Huang, Cheng, Zhu, Xiao-Dong, Xu, Ming-Hao, Chen, Zhao-Shuo, Tan, Chang-Jun, Zhou, Jian, Fan, Jia, Sun, Hui-Chuan
Publicado 2022

Cholecystectomy is associated with higher risk of early recurrence and poorer survival after curative resection for early stage hepatocellular carcinoma

por Li, Tao, Wang, Shu-Kang, Zhi, Xu-Ting, Zhou, Jian, Dong, Zhao-Ru, Zhang, Zong-Li, Sun, Hui-Chuan, Ye, Qing-Hai, Fan, Jia
Publicado 2016

Risk factors affecting prognosis in metachronous liver metastases from WHO classification G1 and G2 gastroenteropancreatic neuroendocrine tumors after initial R0 surgical resection

por Lv, Yang, Han, Xu, Xu, Xue-Feng, Ji, Yuan, Zhou, Yu-Hong, Sun, Hui-Chuan, Zhou, Jian, Fan, Jia, Lou, Wen-Hui, Huang, Cheng
Publicado 2019